Want to see IN:AJANTPHARM full AI Analyst Report?
Ajanta Pharma Limited (AJANTPHARM) Revenue
Ajanta Pharma Limited Revenue
Ajanta Pharma Limited had a revenue of 16.26B in the quarter ending Jun 30, 2026, with 14.37%. This bring the company's revenue in the last twelve months to 57.76B, Increased 5.93%. In the fiscal year ending Mar 31, 2026, Ajanta Pharma Limited had annual revenue of 54.53B with 18.86% growth.
- Revenue (ttm)
- 57.76B
- Revenue Growth
- 25.01%
- P/S Ratio
- 8.05
- Revenue/Employee
- INR 5,232,569
- Employees
- 10,421
- Market Cap
- INR 438.91B
Revenue Chart
Ajanta Pharma Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 54.53B | 8.65B | 18.86% |
| Mar 31, 2025 | 45.88B | 4.26B | 10.23% |
| Mar 31, 2024 | 41.62B | 4.54B | 12.25% |
| Mar 31, 2023 | 37.08B | 4.23B | 12.89% |
| Mar 31, 2022 | 32.84B | 4.39B | 15.43% |
| Mar 31, 2021 | 28.45B | 2.83B | 11.06% |
| Mar 31, 2020 | 25.62B | 5.45B | 27.05% |
| Mar 31, 2019 | 20.16B | -431.40M | -2.09% |
| Mar 31, 2018 | 20.60B | 1.43B | 7.47% |
| Mar 31, 2017 | 19.16B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:AJANTPHARM | 57.76B |
| IN:EMCURE | 42.98B |
| IN:GLENMARK | 169.83B |
| IN:IPCALAB | 96.46B |
| IN:WOCKPHARMA | 35.64B |